USClinicalTrials.govClinical trialNot applicableActive, not recruiting
Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors
Official record
- Identifier
NCT03612531- Recruiting locations
country
United States- Interventions studied
- Manual Therapy
- Lead sponsor
- M.D. Anderson Cancer Center
- Target enrolment
- 26 participants
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Status
- Active, not recruiting
- First posted
- Aug 2, 2018
- Last updated on the registry
- Jul 28, 2026
- Age
- 18 Years
- Sex
- ALL
- Study contact
- No public contact is listed on the official record.
- Eligibility criteria
Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.
Inclusion Criteria: * Late Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) grade \>= 2 dysphagia on Modified Barium Swallow (MBS) \>= 2 years after curative-intent radiotherapy for head and neck cancer * Grade \>= 2 Common Terminology Criteria for Adverse Events (CTCAE) fibrosis * Willing and able to return for 10 sessions over 6 weeks of therapy Exclusion Criteria: * Active recurrent or second primary head and neck, central nervous system, or thoracic cancer at time of enrollment * Active osteoradionecrosis or other non-healing wounds (e.g., fistula, ulcer, soft tissue necrosis) in manual therapy (MT) regions of interest at time of enrollment * History of subtotal or total glossectomy or total laryngectomy * Functionally limiting cardiac, pulmonary, or neuromuscular disease * Current tracheostomy
This site does not provide medical advice
TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.